Article

Problems in Cancer Genome Medicine: Base Mutations Cause Intron Start Signals, Resulting in Unexpected Splicing

2025-05-23

Abstract excerpt

The genetic characteristics of surgically removed cancerous tissues are examined using cancer gene panel testing in cancer genome medicine to detect the pathogenic variants involved in the proliferation and progression of cancer cells. An antitumor drug is prescribed if it directly acts on the detected pathogenic variant; however, some aspects require careful consideration by medical professionals in such cases. T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 738e9f23-3acb-5a04-87cd-b7dae06b6a3f
DOI: 10.20944/preprints202505.1776.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Problems in Cancer Genome Medicine: Base Mutations Cause Intron Start Signals, Resulting in Unexpected SplicingDOI 10.20944/preprints202505.1776.v1Read

Next generation sequencing‐based gene panel tests for the management of solid tumorsSemantic proximity Read

Systematic Analysis of Splice-Site-Creating Mutations in Cancer.Semantic proximity Read

Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients.Semantic proximity Read

MET D1228N and D1246N are the Same Resistance Mutation in MET Exon 14 Skipping.Semantic proximity Read

Hidden dangers: a cryptic exon disrupts BRCA2 mRNA.Semantic proximity Read

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.Semantic proximity Read

Clinical Tumor Sequencing: Opportunities and Challenges for Precision Cancer MedicineSemantic proximity Read

Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan.Semantic proximity Read